Tegaderm
Payments companies reported to CMS as associated with Tegaderm. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tegaderm, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tegaderm
These are the largest totals companies reported as associated with Tegaderm. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Garrett Wirth | Newport Beach, CA | Plastic Surgery | $24,640.00 |
| Emily Greenstein | Fargo, ND | Nurse Practitioner | $20,826.01 |
| Catherine Milne | Plymouth, CT | Nurse Practitioner | $16,698.53 |
| Mark Rupp | Omaha, NE | Infectious Disease | $11,000.00 |
| Kersten Reider | Mount Penn, PA | Primary Care | $10,363.28 |
| Kyle Mueller | Philadelphia, PA | Neurological Surgery | $9,375.00 |
| Timothy Alton | Renton, WA | Orthopaedic Surgery | $8,937.50 |
| Matthew Ostroff | Paterson, NJ | Acute Care (Nurse Practitioner) | $8,763.59 |
| Abhishek Chatterjee | Lebanon, NH | Surgery | $8,470.61 |
| Michael Desvigne | Glendale, AZ | Plastic and Reconstructive Surgery | $8,151.25 |
Prescribed Tegaderm?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.